1. Begg AC (1990) Cisplatin and radiation: interaction probabilities and therapeutic possibilities. Int J Radiat Oncol Biol Phys 19:1183
2. Bowman A, Fergusson RJ, Allan SG, Stewart ME, Gregor A, Cornbleet MA, Greening AP, Crompton GK, Leonard RCF, Smyth JF (1990) Potentiation of cisplatin by alpha-interferon in advanced non-small cell lung cancer (NSCLC): a phase II study. Ann Oncol 1:351
3. Bunn PA Jr, Crowley J, Hazuka R, Tolley R, Livingston R (1992) The role of GMCSF in limited stage SCLC: a randomized phase III study of the Southwest Oncology Group (SWOG). Proc ASCO 11:292
4. Butler RD, Waites TM, Lamar RE, Hainsworth JD, Greco FA, Johnson DH (1992) Timing of GCSF administration during intensive chemotherapy for breast cancer. Proc ASCO 11:403
5. Carmichael J, Fergusson RJ, Wolf CR, Balkwill FR, Smyth JF (1986) Augmentation of cytotoxicity of chemotherapy by human α-Interferons in human non-small-cell lung cancer xenografts. Cancer Res 46:4916